TALEN

TALEN1-foxf2b

ID
ZDB-TALEN-160801-3
Name
TALEN1-foxf2b
Previous Names
None
Target
Target Sequence 1
5' - TGTCAAAGAGTAAAAA - 3'
ZFIN BLAST NCBI BLAST Ensembl
Target Sequence 2
5' - TAGGGCGGTTTCTCCGGG - 3'
ZFIN BLAST NCBI BLAST Ensembl
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
ca22 foxf2b
ca23 foxf2b
Expression
Gene expression in Wild Types + TALEN1-foxf2b
No data available
Phenotype
Phenotype resulting from TALEN1-foxf2b
No data available
Phenotype of all Fish created by or utilizing TALEN1-foxf2b
Phenotype Fish Conditions Figures
brain vasculature pericyte pdgfrb expression decreased amount, abnormal foxf2bca22/ca22 standard conditions Fig. 2 from Neurology Working Group of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium et al., 2016
pericyte cell development decreased occurrence, abnormal foxf2bca22/ca22 standard conditions Fig. 2 from Neurology Working Group of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium et al., 2016
brain vasculature pericyte pdgfrb expression decreased amount, abnormal foxf2bca23/ca23 standard conditions Fig. 2 from Neurology Working Group of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium et al., 2016
pericyte cell development decreased occurrence, abnormal foxf2bca23/ca23 standard conditions Fig. 2 from Neurology Working Group of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium et al., 2016
brain vasculature vascular smooth muscle decreased amount, abnormal foxf2bca22/ca22; ca7Tg standard conditions Fig. 2 from Neurology Working Group of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium et al., 2016
brain vasculature vascular smooth muscle decreased branchiness, abnormal foxf2bca22/ca22; ca7Tg standard conditions Fig. 2 from Neurology Working Group of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium et al., 2016
brain vasculature vascular smooth muscle decreased amount, abnormal foxf2bca23/ca23; ca7Tg standard conditions Fig. 2 from Neurology Working Group of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium et al., 2016
brain vasculature vascular smooth muscle decreased branchiness, abnormal foxf2bca23/ca23; ca7Tg standard conditions Fig. 2 from Neurology Working Group of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium et al., 2016
pericyte GFP expression decreased amount, abnormal foxf2bca22/ca22; foxf2aca71/ca71; ca42Tg; ci5Tg; mpn100Tg standard conditions Fig. S1 from Ryu et al., 2022
pericyte decreased amount, abnormal foxf2bca22/ca22; foxf2aca71/ca71; ca42Tg; ci5Tg; mpn100Tg standard conditions Fig. S1 from Ryu et al., 2022
vasculature hemorrhagic, abnormal foxf2bca22/ca22; foxf2aca71/ca71; la116Tg; sd2Tg standard conditions Fig. S1 from Ryu et al., 2022
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.